ELAVL1 and hepatocellular carcinoma: Another study illustrated that WTAP was highly expressed in hepatocellular carcinoma (HCC) and that WTAP-mediated m6A modifications could promote HCC progression via the HuR-ETS1-p21/p27 axis [43].